Page last updated: 2024-09-04

beta-lactams and Maxillary Sinusitis

beta-lactams has been researched along with Maxillary Sinusitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alefelder, M; Arvis, P; Berg, O; Gehanno, P; Leiberman, A; Martinkenas, JL; Nikolaidis, P; Reimnitz, P; Siegert, R1

Trials

1 trial(s) available for beta-lactams and Maxillary Sinusitis

ArticleYear
Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2003, Volume: 260, Issue:4

    Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefuroxime; Double-Blind Method; Female; Humans; Lactams; Male; Maxillary Sinusitis; Middle Aged; Prospective Studies; Treatment Outcome

2003